About Biopharma Development And Production
- Home |
- About Biopharma Development And Production
"International Conference and Expo on Biopharma Development and Production" Summit will bring together quality leaders to share ideas and discuss the industry's future challenges. Biopharma Expo 2023 Congress will feature experienced speakers, participants, and networking opportunities for academics and industry to discover new opportunities and partnerships. Biopharma Expo 2023 Meetings will also provide opportunities for focused research institutes, government agencies, start-ups, and established companies to address biotechnology and pharmaceutical industry challenges.
Hilaris Conferences believes that access to science is critical to long-term development, and this platform will undoubtedly foster new collaborations between academics and industry, policymakers, innovators, investors, and government agencies. Hilaris Conferences seeks global attendance support for the vision towards tomorrow.
"International Conference and Expo on Biopharma Development and Production" will be held in London, UK by Hilaris Conferences. This platform will facilitate networking and collaboration among academic, industry, and government representatives. Attendence at the Biopharma Expo 2023 Conference will share new insights and developments in biotechnology, pharma, and related fields. Participants will come from research institutes, CROs and analytical labs, CMOs, clinics, biotechnology, and pharmaceutical companies.
Scope/ Target Audience:
The global biopharma development and manufacturing industry is expanding rapidly. Industry Researchers, Chief Executive Officers, Directors, Chief Scientific Officers, Chief Medical Officers, Head of Regulatory Affairs, Chief Operating Officer, Head of Legal & Intellectual Property, Research Heads, Consultants, Business Development & Sales Teams, Policymakers, Investors, Government Officials, and other participants are cordially invited to attend the Biopharma Expo 2023 Meetings.
Participants from Academia/Universities/Hospitals:
Biopharma Expo 2023 Congress welcomes Directors, Deans, Lab Heads, Scientists, Clinicians, Doctors, and Students with an interest in drug discovery and development, drug delivery, analytical and bioanalytical techniques, biopharmaceutical manufacturing, clinical trials, intellectual property, and regulatory affairs, among others.
The global biopharmaceuticals market was valued at $186,470 million in 2017 and is expected to reach $390,210 million by 2023, growing at a 13.8% CAGR between 2017 and 2023. The global biopharmaceuticals market is being driven by a variety of factors, including an increase in the elderly population, the prevalence of diseases such as diabetes, obesity, and cancer, and an increase in biopharmaceutical adoption year over year. Furthermore, the increase in strategic collaborations among biopharmaceutical corporations is expected to supplement the growth of the biopharmaceuticals industry.
Emerging economies such as China, Singapore, and India are expected to provide profitable growth opportunities for key players in the biopharmaceuticals market. However, the costs of drug development are high, and failure is common.